Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 19 Researches
7.4
USERS' SCORE
Good
Based on 4 Reviews
8.5
Supplement Facts
Serving Size: 1 Veg Capsule
Amount Per Serving
%DV
Blend of Probiotic Bacteria:Lactobacillus acidophilus (La-14),Bifidobacterium lactis (Bl-04),Bifidobacterium longum (Bl-05)
8 Billion CFU
*
Top Medical Research Studies
9
We explored the potential of Lactobacillus acidophilus KBL409 in addressing atopic dermatitis, a common form of eczema. By using a mouse model induced by house dust mites, we found that administering this probiotic led to significantly lower dermatitis scores and less immune cell infiltration in the skin.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
Read More
9
We conducted a thorough investigation on the effects of Lactobacillus acidophilus L-92 in adults with atopic dermatitis.
In a placebo-controlled, double-blinded study, we observed 50 patients who consumed either L-92 or a placebo for 24 weeks.
Results showed that those taking L-92 had notable improvements in skin symptoms over time, including reduced severity and incidents of scratching.
Overall, the findings suggest that L-92 might play a beneficial role in managing eczema symptoms.
In a placebo-controlled, double-blinded study, we observed 50 patients who consumed either L-92 or a placebo for 24 weeks.
Results showed that those taking L-92 had notable improvements in skin symptoms over time, including reduced severity and incidents of scratching.
Overall, the findings suggest that L-92 might play a beneficial role in managing eczema symptoms.
Read More
9
We examined how early supplementation with Bifidobacterium lactis HN019 could influence the development of eczema over a decade. Our randomized controlled trial showed promising results using the Lactobacillus rhamnosus HN001, which significantly helped in reducing eczema prevalence and other allergic conditions like hay fever and atopy by age 11.
However, we found no beneficial effect from HN019. This groundbreaking study demonstrates that probiotic interventions in early life can positively shape health outcomes for eczema and allergies well into childhood.
However, we found no beneficial effect from HN019. This groundbreaking study demonstrates that probiotic interventions in early life can positively shape health outcomes for eczema and allergies well into childhood.
Read More
Most Useful Reviews
9
Eczema improvement
11 people found this helpful
I have suffered from hand eczema for about a year. After starting biotin therapy alongside vitamin C and an intestinal regulator, my eczema ceased within 10 days, and my skin became more vibrant. I am grateful I discovered this treatment.
Read More
7.5
Eczema clearance
6 people found this helpful
My niece's eczema cleared up after she began taking Acidophilus for digestive issues. I tried it too, and my eczema on my elbows disappeared as well.
Read More
9
Eczema healing
5 people found this helpful
My health examination revealed a high level of bad bacteria, which I suspect contributed to my eczema and itching on my hand. Since taking Candida support and biotin, my stools have improved, my skin looks healthier, and the eczema has diminished significantly. This supplement is essential for me!
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 19 Researches
7.4
- All Researches
9.5
We studied whether giving probiotics to expecting and breastfeeding mothers could help lower the risk of eczema in their infants. In a well-structured trial, 241 mother-infant pairs participated, with some mothers receiving probiotics and others receiving a placebo.
Over two years, we found that infants born to mothers who took Bifidobacterium longum and other probiotics had a significantly reduced risk of developing eczema. This approach appeared safe, with no reported adverse effects, although probiotics did not impact atopic sensitization rates.
Over two years, we found that infants born to mothers who took Bifidobacterium longum and other probiotics had a significantly reduced risk of developing eczema. This approach appeared safe, with no reported adverse effects, although probiotics did not impact atopic sensitization rates.
Read More
9
We explored the potential of Lactobacillus acidophilus KBL409 in addressing atopic dermatitis, a common form of eczema. By using a mouse model induced by house dust mites, we found that administering this probiotic led to significantly lower dermatitis scores and less immune cell infiltration in the skin.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
Read More
9
We conducted a thorough investigation on the effects of Lactobacillus acidophilus L-92 in adults with atopic dermatitis.
In a placebo-controlled, double-blinded study, we observed 50 patients who consumed either L-92 or a placebo for 24 weeks.
Results showed that those taking L-92 had notable improvements in skin symptoms over time, including reduced severity and incidents of scratching.
Overall, the findings suggest that L-92 might play a beneficial role in managing eczema symptoms.
In a placebo-controlled, double-blinded study, we observed 50 patients who consumed either L-92 or a placebo for 24 weeks.
Results showed that those taking L-92 had notable improvements in skin symptoms over time, including reduced severity and incidents of scratching.
Overall, the findings suggest that L-92 might play a beneficial role in managing eczema symptoms.
Read More
9
We examined how early supplementation with Bifidobacterium lactis HN019 could influence the development of eczema over a decade. Our randomized controlled trial showed promising results using the Lactobacillus rhamnosus HN001, which significantly helped in reducing eczema prevalence and other allergic conditions like hay fever and atopy by age 11.
However, we found no beneficial effect from HN019. This groundbreaking study demonstrates that probiotic interventions in early life can positively shape health outcomes for eczema and allergies well into childhood.
However, we found no beneficial effect from HN019. This groundbreaking study demonstrates that probiotic interventions in early life can positively shape health outcomes for eczema and allergies well into childhood.
Read More
8
We evaluated the effects of L-92—a paraprobiotic—on young children suffering from atopic dermatitis (AD) and food allergies. In a study of 59 children aged 10 months to 3 years, participants were given either L-92 or a placebo alongside standard AD treatment over 24 weeks.
The results showed a meaningful decrease in eczema severity in the L-92 group compared to baseline evaluations. Improvements in immune markers like TARC and total IgE levels were also documented. This indicates that L-92 may serve as an effective additional treatment for young children dealing with AD and food allergies.
The results showed a meaningful decrease in eczema severity in the L-92 group compared to baseline evaluations. Improvements in immune markers like TARC and total IgE levels were also documented. This indicates that L-92 may serve as an effective additional treatment for young children dealing with AD and food allergies.
Read More
User Reviews
USERS' SCORE
Good
Based on 4 Reviews
8.5
- All Reviews
- Positive Reviews
- Negative Reviews
9
Eczema improvement
11 people found this helpful
I have suffered from hand eczema for about a year. After starting biotin therapy alongside vitamin C and an intestinal regulator, my eczema ceased within 10 days, and my skin became more vibrant. I am grateful I discovered this treatment.
Read More
7.5
Eczema clearance
6 people found this helpful
My niece's eczema cleared up after she began taking Acidophilus for digestive issues. I tried it too, and my eczema on my elbows disappeared as well.
Read More
9
Eczema healing
5 people found this helpful
My health examination revealed a high level of bad bacteria, which I suspect contributed to my eczema and itching on my hand. Since taking Candida support and biotin, my stools have improved, my skin looks healthier, and the eczema has diminished significantly. This supplement is essential for me!
Read More
9
Eczema relief
This product has greatly improved my digestion and eczema issues, allowing me to eat a wider variety of foods. I believe it also helps to keep Candida at bay. For both the price and quality, I cannot recommend this probiotic enough.
Read More
Frequently Asked Questions
9
Eczema improvement
11 people found this helpful
I have suffered from hand eczema for about a year. After starting biotin therapy alongside vitamin C and an intestinal regulator, my eczema ceased within 10 days, and my skin became more vibrant. I am grateful I discovered this treatment.
7.5
Eczema clearance
6 people found this helpful
My niece's eczema cleared up after she began taking Acidophilus for digestive issues. I tried it too, and my eczema on my elbows disappeared as well.
9
Eczema healing
5 people found this helpful
My health examination revealed a high level of bad bacteria, which I suspect contributed to my eczema and itching on my hand. Since taking Candida support and biotin, my stools have improved, my skin looks healthier, and the eczema has diminished significantly. This supplement is essential for me!
9
Eczema relief
This product has greatly improved my digestion and eczema issues, allowing me to eat a wider variety of foods. I believe it also helps to keep Candida at bay. For both the price and quality, I cannot recommend this probiotic enough.
9
We explored the potential of Lactobacillus acidophilus KBL409 in addressing atopic dermatitis, a common form of eczema. By using a mouse model induced by house dust mites, we found that administering this probiotic led to significantly lower dermatitis scores and less immune cell infiltration in the skin.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
Additionally, L. acidophilus KBL409 reduced serum immunoglobulin E and influenced various cytokines linked to inflammation. It also positively affected gut microbiota and concentrations of beneficial compounds, hinting at a broader impact on our immune responses. Overall, our findings suggest that L. acidophilus KBL409 may be a promising probiotic for eczema management.
7
We assessed how effective nutritional supplements, including probiotics like lactobacillus acidophilus, are for managing eczema symptoms.
Our analysis revealed weak evidence overall for any one supplement, though some, especially probiotics, showed potential benefits.
Specifically, lactobacillus acidophilus is linked to positive outcomes in several studies.
However, we found that larger trials are necessary for a clearer understanding of these supplements' impact on eczema across a wider population.
Our analysis revealed weak evidence overall for any one supplement, though some, especially probiotics, showed potential benefits.
Specifically, lactobacillus acidophilus is linked to positive outcomes in several studies.
However, we found that larger trials are necessary for a clearer understanding of these supplements' impact on eczema across a wider population.
8
We evaluated the effects of L-92—a paraprobiotic—on young children suffering from atopic dermatitis (AD) and food allergies. In a study of 59 children aged 10 months to 3 years, participants were given either L-92 or a placebo alongside standard AD treatment over 24 weeks.
The results showed a meaningful decrease in eczema severity in the L-92 group compared to baseline evaluations. Improvements in immune markers like TARC and total IgE levels were also documented. This indicates that L-92 may serve as an effective additional treatment for young children dealing with AD and food allergies.
The results showed a meaningful decrease in eczema severity in the L-92 group compared to baseline evaluations. Improvements in immune markers like TARC and total IgE levels were also documented. This indicates that L-92 may serve as an effective additional treatment for young children dealing with AD and food allergies.
7
We explored how a specific probiotic, Bio-K+, could potentially help adults with chronic hand eczema when taken for 12 weeks. This single-center study focused on patients not in acute flare-ups, combined with standard treatments.
Out of 30 participants, nearly 63% reported improvements in their condition, with noticeable relief from itching early on. Although results varied, 23% achieved clear or nearly clear skin by the study’s end, highlighting the probiotic's promise as a supportive treatment.
Out of 30 participants, nearly 63% reported improvements in their condition, with noticeable relief from itching early on. Although results varied, 23% achieved clear or nearly clear skin by the study’s end, highlighting the probiotic's promise as a supportive treatment.
References
- Kim WK, Jang YJ, Park S, Min SG, Kwon H, et al. Lactobacillus acidophilus KBL409 Ameliorates Atopic Dermatitis in a Mouse Model. J Microbiol. 2024;62:91. doi:10.1007/s12275-024-00104-5
- Weber I, Woolhiser E, Keime N, Wasvary M, Adelman MJ, et al. Clinical Efficacy of Nutritional Supplements in Atopic Dermatitis: Systematic Review. JMIR Dermatol. 2023;6:e40857. doi:10.2196/40857
- Nakata J, Hirota T, Umemura H, Nakagawa T, Kando N, et al. Additive effect of L-92 on children with atopic dermatitis concomitant with food allergy. Asia Pac Allergy. 2019;9:e18. doi:10.5415/apallergy.2019.9.e18
- Gulliver WP, Hutton AS, Ship N. Investigating the therapeutic potential of a probiotic in a clinical population with chronic hand dermatitis. Clin Cosmet Investig Dermatol. 2018;11:265. doi:10.2147/CCID.S164748
- Yamamoto K, Yokoyama K, Matsukawa T, Kato S, Kato S, et al. Efficacy of prolonged ingestion of Lactobacillus acidophilus L-92 in adult patients with atopic dermatitis. J Dairy Sci. 2016;99:5039. doi:10.3168/jds.2015-10605
- Dotterud CK, Storrø O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol. 2010;163:616. doi:10.1111/j.1365-2133.2010.09889.x
- Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol. 2010;21:e386. doi:10.1111/j.1399-3038.2009.00958.x
- Puisto R, Gómez-Gallego C, Collado MC, Turta O, Isolauri E, et al. The Role of Infant Gut Microbiota Modulation by Perinatal Maternal Probiotic Intervention in Atopic Eczema Risk Reduction. Neonatology. 2025;122:84. doi:10.1159/000540075
- Enomoto T, Sowa M, Nishimori K, Shimazu S, Yoshida A, et al. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol Int. 2014;63:575. doi:10.2332/allergolint.13-OA-0683
- Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130:1355. doi:10.1016/j.jaci.2012.09.003
- Adjibade M, Vigneron L, Delvert R, Adel-Patient K, Divaret-Chauveau A, et al. Characteristics of infant formula consumed in the first months of life and allergy in the EDEN mother-child cohort. Matern Child Nutr. 2024;20:e13673. doi:10.1111/mcn.13673
- Schmidt RM, Pilmann Laursen R, Bruun S, Larnkjaer A, Mølgaard C, et al. Probiotics in late infancy reduce the incidence of eczema: A randomized controlled trial. Pediatr Allergy Immunol. 2019;30:335. doi:10.1111/pai.13018
- Wickens K, Barthow C, Mitchell EA, Kang J, van Zyl N, et al. Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years. Pediatr Allergy Immunol. 2018;29:808. doi:10.1111/pai.12982
- Kim HK, Rutten NB, Besseling-van der Vaart I, Niers LE, Choi YH, et al. Probiotic supplementation influences faecal short chain fatty acids in infants at high risk for eczema. Benef Microbes. 2015;6:783. doi:10.3920/BM2015.0056
- Marlow G, Han DY, Wickens K, Stanley T, Crane J, et al. Differential effects of two probiotics on the risks of eczema and atopy associated with single nucleotide polymorphisms to Toll-like receptors. Pediatr Allergy Immunol. 2015;26:262. doi:10.1111/pai.12371
- Niers L, Martín R, Rijkers G, Sengers F, Timmerman H, et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy. 2009;64:1349. doi:10.1111/j.1398-9995.2009.02021.x
- Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008;122:788. doi:10.1016/j.jaci.2008.07.011
- Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?. Gut. 2002;51:51.
- Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30:1604.
